These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 31599686)
1. The Daunting Economics of Therapeutic Genome Editing. Wilson RC; Carroll D CRISPR J; 2019 Oct; 2(5):280-284. PubMed ID: 31599686 [TBL] [Abstract][Full Text] [Related]
2. Heritable Genome Editing and the Downsides of a Global Moratorium. Macintosh KL CRISPR J; 2019 Oct; 2(5):272-279. PubMed ID: 31599680 [TBL] [Abstract][Full Text] [Related]
3. Heritable Genome Editing: Who Speaks for "Future" Children? Knoppers BM; Kleiderman E CRISPR J; 2019 Oct; 2(5):285-292. PubMed ID: 31599679 [TBL] [Abstract][Full Text] [Related]
5. The role of scientific self-regulation for the control of genome editing in the human germline: The lessons from the Asilomar and the Napa meetings show how self-regulation and public deliberation can lead to regulation of new biotechnologies. Gregorowius D; Biller-Andorno N; Deplazes-Zemp A EMBO Rep; 2017 Mar; 18(3):355-358. PubMed ID: 28219901 [TBL] [Abstract][Full Text] [Related]
6. Walk the Line: Debating a Germline Editing Moratorium. Davies K CRISPR J; 2019 Apr; 2():74-76. PubMed ID: 30998090 [No Abstract] [Full Text] [Related]
7. Human dignity and gene editing: Using human dignity as an argument against modifying the human genome and germline is a logical fallacy. de Miguel Beriain I EMBO Rep; 2018 Oct; 19(10):. PubMed ID: 30237156 [TBL] [Abstract][Full Text] [Related]
8. The New RNA-Editing Era - Ethical Considerations. Gold A; Levanon EY; Eisenberg E Trends Genet; 2021 Aug; 37(8):685-687. PubMed ID: 33975753 [TBL] [Abstract][Full Text] [Related]
9. User-Friendly Technology the Key to Gene-Editing's Bloom: Market for Gene-Editing Tools Estimated at $608m and Growing as New Applications Are Found. Carlson B Hum Gene Ther Clin Dev; 2016 Dec; 27(4):137-139. PubMed ID: 27983891 [No Abstract] [Full Text] [Related]
10. The illusion of control in germline-engineering policy. König H Nat Biotechnol; 2017 Jun; 35(6):502-506. PubMed ID: 28591117 [No Abstract] [Full Text] [Related]
11. Democratic Governance of Human Germline Genome Editing. Jasanoff S; Hurlbut JB; Saha K CRISPR J; 2019 Oct; 2(5):266-271. PubMed ID: 31599682 [TBL] [Abstract][Full Text] [Related]
12. Ethical issues of CRISPR technology and gene editing through the lens of solidarity. Mulvihill JJ; Capps B; Joly Y; Lysaght T; Zwart HAE; Chadwick R; Br Med Bull; 2017 Jun; 122(1):17-29. PubMed ID: 28334154 [TBL] [Abstract][Full Text] [Related]
13. Genome editing: progress and challenges for medical applications. Carroll D Genome Med; 2016 Nov; 8(1):120. PubMed ID: 27846896 [TBL] [Abstract][Full Text] [Related]
14. The Smart Programmable CRISPR Technology: A Next Generation Genome Editing Tool for Investigators. Chakraborty C; Teoh SL; Das S Curr Drug Targets; 2017; 18(14):1653-1663. PubMed ID: 27231109 [TBL] [Abstract][Full Text] [Related]
15. The Ethics of Heritable Genome Editing: New Considerations in a Controversial Area. Adashi EY; Cohen IG JAMA; 2018 Dec; 320(24):2531-2532. PubMed ID: 30508029 [No Abstract] [Full Text] [Related]
16. [The Washington summit: orange light for genome editing?]. Jordan B Med Sci (Paris); 2016 Feb; 32(2):217-20. PubMed ID: 26936181 [TBL] [Abstract][Full Text] [Related]
18. In Our Image: The Ethics of CRISPR Genome Editing. Eissenberg JC Biomol Concepts; 2021 Jan; 12(1):1-7. PubMed ID: 33544462 [TBL] [Abstract][Full Text] [Related]
19. Recent Advances in Therapeutic Genome Editing in China. Yang Y; Wang Q; Li Q; Men K; He Z; Deng H; Ji W; Wei Y Hum Gene Ther; 2018 Feb; 29(2):136-145. PubMed ID: 29446996 [TBL] [Abstract][Full Text] [Related]
20. Reproductive medicine involving genome editing: clinical uncertainties and embryological needs. Ishii T Reprod Biomed Online; 2017 Jan; 34(1):27-31. PubMed ID: 27743815 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]